Mepantin en es it fr

Mepantin Brand names, Mepantin Analogs

Mepantin Brand Names Mixture

  • No information avaliable

Mepantin Chemical_Formula


Mepantin RX_link

No information avaliable

Mepantin fda sheet

Mepantin msds (material safety sheet)

Mepantin Synthesis Reference

No information avaliable

Mepantin Molecular Weight

309.469 g/mol

Mepantin Melting Point

< 25 oC

Mepantin H2O Solubility

Soluble as HCl salt

Mepantin State


Mepantin LogP


Mepantin Dosage Forms

Tablets (oral, 1 mg)

Mepantin Indication

Used for the symptomatic treatment of parkinsonism.

Mepantin Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Mepantin Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Mepantin side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Mepantin Patient Information

Mepantin Organisms Affected

Humans and other mammals